Senate Panel Passes Bills to Increase Competition and Increase List Price Transparency
For Immediate Release
Contact: Jon Conradi
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today on the advancement of several bipartisan solutions that will help hold Big Pharma accountable by the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP).
“CSRxP commends the leadership and members of the HELP Committee for advancing bipartisan, market-based solutions that will support greater competition from more affordable alternatives and shine a light on Big Pharma’s most egregious pricing practices,” said CSRxP executive director Lauren Aronson. “Big Pharma companies are responsible for setting and increasing prices on their products and lawmakers must continue to focus on holding them accountable to lower prescription drug prices for patients, including by passing these solutions into law.”
CSRxP-supported legislation passed by the HELP Committee on Thursday includes:
Read CSRxP’s letter to the Senate HELP Committee on the markup of this legislation HERE.
Learn more about how list price transparency can help lower drug prices and hold Big Pharma accountable HERE.
Read more on market-based solutions to hold Big Pharma accountable and lower prescription drug prices HERE.